Executive Director, Early Phase Development Solutions (EPDS) Science & Strategy

Job Location(s) UK-Harrogate | US-WI-Madison | US-MI-Ann Arbor | US-VA-Chantilly | UK-Eye | UK-Huntingdon | DE-Muenster, Westfalen | US-CA-San Carlos | UK-Shardlow | US-NJ-Somerset
Job Number
Job Category
Scientific Advanced
Position Type

Job Overview

This is an exciting opportunity to join Labcorp leading our highly successful Early Phase Development Solutions (EPDS) Science & Strategy team.  We are keen to find an experienced leader in drug development to implement and deliver a successful strategy to enable growth of a portfolio of innovative and profitable programs. 
Are you?
- Someone with passion, drive and energy to create scientific value, deliver the EPDS strategy to ensure client satisfaction and to deliver financial success to Labcorp?
- Someone who will proactively and closely partner with our commercial team to identify key opportunities as well as build sustainable client relationships?
- An expert in drug development, willing to lead a team of experts, Drug Development Leaders (DDL), to provide clients with bespoke consultancy and advisory services to help them develop their molecule(s) in an efficient and timely manner?  
If you are a visionary, inspirational leader; strong evidence of being able to develop and deliver a credible vision that others will follow and have a track record of high performance in the 4 key leadership areas of; People, Science, Business and Strategy we would like to hear from you.
You and your team will provide scientific leadership and direction to our clients and to Labcorp solutions development teams in Early Development as well as seeking opportunities to partner across the enterprise engaging in other potential and awarded programs.


- PhD in an appropriate scientific discipline; additional advanced degree is helpful.
- Background and training in toxicology, immunology, vaccines, BioCMC or DMPK is required


Minimum Experience Required:
- PhD, MD or appropriate relevant experience with extensive knowledge of drug development in particular in the LO to clinical POC space. Experience of late stage drug development would be an advantage.
- Minimum of 15 years’ scientific expertise demonstrated in the pharmaceutical industry, biopharmaceutical or CRO industry specifically related to the drug development process, with an emphasis on biopharmaceuticals and/or pharmaceuticals development
- Demonstrated experience in progressing molecules from early pre-clinical into clinical development
- 5+ years representing a functional area, such as Toxicology, BioPharmCMC, or ADME on molecule development teams
- 5+ years of global leadership experience, ideally in a complex, virtual and matrix environment leading multi-functional teams across disciplines and departmental lines/functions
- Understands the drug development business including the different considerations and driving forces in the emerging, mid and large biopharm sectors
- An up to date awareness of ICH and regional Regulatory Guidelines as well as industry trends is essential


Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed